- Home
- ARAY vs DHF Comparison
ARAY vs DHF Comparison
Compare ARAY & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARAY
- DHF
- Stock Information
- Founded
- ARAY 1990
- DHF 1998
- Country
- ARAY United States
- DHF United States
- Employees
- ARAY N/A
- DHF N/A
- Industry
- ARAY Medical/Dental Instruments
- DHF Finance Companies
- Sector
- ARAY Health Care
- DHF Finance
- Exchange
- ARAY Nasdaq
- DHF Nasdaq
- Market Cap
- ARAY 180.0M
- DHF 188.4M
- IPO Year
- ARAY 2007
- DHF N/A
- Fundamental
- Price
- ARAY $2.24
- DHF $2.62
- Analyst Decision
- ARAY Strong Buy
- DHF
- Analyst Count
- ARAY 1
- DHF 0
- Target Price
- ARAY $9.00
- DHF N/A
- AVG Volume (30 Days)
- ARAY 669.1K
- DHF 451.1K
- Earning Date
- ARAY 01-29-2025
- DHF 01-01-0001
- Dividend Yield
- ARAY N/A
- DHF 7.65%
- EPS Growth
- ARAY N/A
- DHF N/A
- EPS
- ARAY N/A
- DHF N/A
- Revenue
- ARAY $444,204,000.00
- DHF N/A
- Revenue This Year
- ARAY $6.64
- DHF N/A
- Revenue Next Year
- ARAY $5.69
- DHF N/A
- P/E Ratio
- ARAY N/A
- DHF N/A
- Revenue Growth
- ARAY N/A
- DHF N/A
- 52 Week Low
- ARAY $1.40
- DHF $2.06
- 52 Week High
- ARAY $2.99
- DHF $2.39
- Technical
- Relative Strength Index (RSI)
- ARAY 60.03
- DHF 57.34
- Support Level
- ARAY $2.04
- DHF $2.53
- Resistance Level
- ARAY $2.34
- DHF $2.62
- Average True Range (ATR)
- ARAY 0.15
- DHF 0.03
- MACD
- ARAY 0.03
- DHF 0.01
- Stochastic Oscillator
- ARAY 82.76
- DHF 100.00
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. It invests predominantly in fixed-income securities of below-investment-grade credit quality.